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Serum cholinesterase (butyrylcholinesterase, acylcholine-acylhydrolase, EC 3.1.1.8)
is an enzyme with no known physiological function. However, it is a marker of
organophosphate and carbamate exposure, as any reduction in its activity suggests
absorption of these compounds. This enzyme is responsible for the breakdown of short-
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The measurement of cholinesterase activity is an
important function of a clinical laboratory.
Participation in appropriate quality assurance
schemes is essential in ensuring a high analytical
standard. Samples of human serum were
distributed to thirty-five laboratories for the
measurement of cholinesterase activity. Because
of methodological differences between the
participants, findings of each laboratory were
compared either by the use of duplicate samples
or by analysis of six mixtures of two samples, one
having a high and one a low activity. Of 4,964
distributed samples 95% were analysed and
findings reported in 596 reports. Thirty-four percent
of all reports were considered very good (less than
5% within-run error) and 38% less than satisfactory
(within-run error over 10%). Access to a
proficiency programme such as this enables
laboratories to evaluate the quality of their
analytical service.
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 Individuals with low cholinesterase activity or certain genetic abnormalities hydrolyse
them slowly, which puts them at risk, since the prolonged action of these relaxants paralyses
the respiratory muscles. Unless artificial ventilation is continued, death will occur. Finally,
since the enzyme is synthesised in the liver, a decrease in its activity occurs in circumstances
of impaired liver function. For all these reasons, the accurate measurement of serum
cholinesterase activity is important in clinical practice (1-3).
In order to give laboratories an opportunity to assess their ability to measure the
enzyme activity reliably, a Proficiency Programme was designed by the Cholinesterase
Investigation Unit of St James’s University Hospital in Leeds, UK. Experience in the
organisation of the scheme and analysis of results was assisted by an earlier investigation
into cholinesterase phenotyping undertaken in the same unit (4,5). Thirty-five laboratories
from the United Kingdom, Canada, Croatia, and New Zealand participated initially. During
the four and a half years that the programme continued, five laboratories discontinued the
assay either because they were unable to maintain a satisfactory standard of performance
or for other reasons. Seven other laboratories joined in later.
METHODS, DISTRIBUTION OF SPECIMENS,
AND REPORTING OF RESULTS
Before entering the programme all laboratories were required to complete a questionnaire
providing details of their analytical procedure and the frequency of its performance.
Approximately half of the participants used benzoylcholine as the substrate and the
remainder acetyl-, propionyl- or butyryl-thiocholines either at 25 °C or 37 °C. Methods
followed those originally published or were adapted from Kalow (6) and Ellman and co-
workers (7). At the beginning of each year, a timetable was set giving the dates for the
distribution of specimens and the deadlines for the return of analytical findings. It also
indicated when cumulative reports could be expected. Results not received by the specified
date were excluded from consideration and classified as “no report”.
Serum was provided by human volunteers. Eight specimens in all but one run were
distributed in volumes of approximately 0.3 ml every three months, 18 runs in all. On
fourteen occasions one specimen had a zero or low activity (A) and one a high activity
(B). The remaining six specimens were mixtures of A and B in proportions decided upon
by the organiser. A and B were distributed randomly among the eight specimens. On four
occasions the eight samples comprised four pairs of duplicates. The activity of specimens
varied between zero and 1.3 µmol/min/ml with benzoylcholine as substrate. Specimen B
was usually serum taken from one of the organisers (Robert T. Evans).
Since the delay in transit would have given overseas laboratories a shorter time to
perform their analyses than those in the United Kingdom, all material destined for
participants outside the UK was posted several days earlier. Because of inherent stability,
serum cholinesterase specimens were shipped at ambient temperature.
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CALCULATIONS
In view of the wide variation in methods and in order to provide a valid comparison of
results between laboratories, the measured activities of specimens A and B for each
participant were plotted at positions 0 and 10 on an arbitrary scale (Figure 1). The activities
of the six other specimens were then inserted in positions depending on their content of A
and B. For example, the position of a mixture A:B=40:60 was 6.0. If all activities are
measured without error the six points fall on a straight line joining the activities of A and B
(Figure 1).
Figure 1 Cholinesterase activity of serum samples measured with good and poor performance.
A and B were specimens with the lowest and the highest activities, and the other six specimens
mixtures of the two. The abscissa is on an arbitrary scale from 0 to 10, and the positions of the six
specimens reflect the proportion of B in the mixture. The scale on the ordinate varies according to the
range of activities in the eight specimens.
Arbitrary scale Arbitrary scale
Absolute difference between each observed activity and that expected (taken from
the line of the A-B plot) was calculated and expressed as a percentage of expected activity.
For every single laboratory the A-B plot was constructed using the reported values for
each run, and the expected values of six other specimens were then read from the straight
line on the A-B plot. The within-run imprecision of measurements was evaluated for the
six mixture specimens (that is, not for A and B). The imprecision of duplicate measurements
was evaluated by expressing the differences between duplicates as a percentage of the
mean.
Any absolute difference of less than 2% was considered excellent. Results between 2
and 5% were regarded as very good, and between 5 and 10% as satisfactory. Differences
Simeon-Rudolf V, Evans RT. INTERLABORATORY STUDY OF CHOLINESTERASE ACTIVITY MEASUREMENT
Arh Hig Rada Toksikol 2001;52:299-305
GOOD PERFORMANCE POOR PERFORMANCE
302
Of the 596 reports which contained the results of a complete series of eight specimens,
38% had at least one difference greater than 10% between the measured and expected
value or between the duplicates (Table 1). An improvement in the performance of
greater than 10% were less than satisfactory. The organiser based these performance
criteria on proposed analytical goal-setting in clinical chemistry, particularly for
cholinesterase activity measurements (8-11).
In average, sixteen laboratories performed their measurements using benzoylcholine
as the substrate at 25 °C. We believed that the number of results sufficed for a statistical
analysis. This enabled comparison between individual laboratory measurements and those
of the group. Each specimen was calculated the mean, standard deviation (SDgroup) and
coefficient of variation (CVgroup) of the reported activities for the group. Any result falling
outside three standard deviations was excluded and the calculation was repeated. Each
activity measurement was then reported in terms of its divergence from the mean value of
the group.
Differences between duplicates were the basis for testing the imprecision of
measurements undertaken using benzoylcholine or thiocholines as substrates
(benzoylcholine and thiocholine laboratory groups). A Mann-Whitney nonparametric test
was used to establish the difference between the medians of the two groups. Differences
between distribution profiles for the two groups were tested by the Kolmogorov-Smirnov
two-sample test, which is based upon distances between cumulative distribution functions.
Statistical analysis (12) was performed using the Microsoft Excel and Statgraphics
Plus programme package.
RESULTS
Of the 4,964 specimens distributed, 4,737 (95%) were reported upon (Table 1). We consider
this a satisfactory response. All laboratories received cumulative data tables and a figure
illustrating their own results (Figure 1).
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Table 1 Summary of serum cholinesterase activity measurements reported during the first
and second half of the programme. Differences between measured and
expected activities are expressed as a percentage of the expected value,
and between duplicate specimens as a percentage of the mean.
Of the total number of reports, 28% were with differences between 5 and 10%.
Number of reports
received during With all differences With all differences With at least one
the programme less than 2% less than 5% difference greater
than 10%
First half 292 6 69 124
Second half 304 24 105 105
Total 596 (100%) 30 (5%) 174 (29%) 229 (38%)
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participants was observed in the second part of the programme with the drop in the number
of differences greater than 10% and increase in the number of differences of less than 5%.
This improvement is partly the result of the withdrawal of a number of centres dissatisfied
with their own performance. We recognise that an error in the measurement of the activity
of either A or B specimens affects the interpretation of those of 1-6 even if 1-6 may have
been analysed appropriately. In only 19 reports did a positive or negative shift of activities
of all six specimens suggest an error in the measurement of either A or B.
The results obtained using benzoylcholine were compared with those using the three
thiocholine esters by analysis of the difference between duplicates for thirty sets of duplicates
which were part of the programme (Table 2). Both groups were had asymmetric
distributions, the skewness being 4.9 and 7.6 for benzoylcholine and the thiocholines,
respectively (Table 2). A significant difference between the two groups was found by
means of the Mann-Whitney test (significance levels <0.001).
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Table 2 Average and median differences (%) between duplicate activity
measurements and skewness of distribution of differences for measurements
by benzoylcholine and by thiocholine substrates.
Substrate Number of pairs Differences (%)
 of duplicate results Average Median Skewness
Benzoylcholine 438 4.4 2.7 4.9
Thiocholine esters 470 3.0 1.5 7.6
The median of the difference between duplicates for the thiocholine group was significantly
lower than that for benzoylcholine. The same significance of difference between the groups
was obtained when we omitted differences greater than 30% (nine and seven results for
benzoylcholine and thiocholine group, respectively) which we considered to be random
errors. A higher frequency of lower values (less than 10%) was found for thiocholine than
for benzoylcholine group, as shown by the Kolmogorov-Smirnov test. This is in accordance
with an earlier report of a lower precision of benzoylcholine than of acetylthiocholine in
measuring cholinesterase activity (13). Because the two groups of participants may have
differed in the technical level and because both the averages and medians of differences
for both groups were less than 5%, we do not think that thiocholine esters are sufficiently
superior to benzoylcholine to recommend laboratories which use benzoylcholine to change
the substrate.
CONCLUSION
Any clinical laboratory undertaking biochemical investigations must maintain a reliable
standard of analytical work in order for correct conclusions to be drawn and appropriate
advice offered to patients. During the period covered by this programme, participating
laboratories were given the opportunity to assess the accuracy and reproducibility of their
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assays. Through this experience they were able to recognise their ability or otherwise to
reach acceptable analytical standards and take steps when necessary to either improve or
discontinue the test. Their activity led to an improvement in performance during the
programme.
It is evident from our study that it is not easy to attain the quality of cholinesterase
measurement which we regard good or excellent, and that a significant proportion of
results, even when issued by laboratories very committed to the achievement of high
standards, are less than satisfactory. Although internal systems of quality control are
essential in analytical laboratories, an external programme such as the one described in
this paper provides additional confidence in the results obtained and hence the advice
given.
Acknowledgements
We wish to thank Mr David Rushton for his skilled technical assistance. We also
sincerely thank our colleagues who participated in this interlaboratory study for their
enthusiasm and helpful suggestions. This paper was part of an ALIS project supported by
the British Council in Zagreb, Croatia and the Ministry of Science and Technology of the
Republic of Croatia.
REFERENCES
1. Evans RT. Cholinesterase phenotyping: clinical aspects and laboratory applications. CRC Crit
Rev Clin Lab Sci 1986;23:35-64.
2. Whittaker M. Cholinesterase. Monographs in human genetics. Basel: Karger AG; 1986.
3. McQueen MJ. Clinical and analytical considerations in the utilization of cholinesterase
measurements. Clin Chim Acta 1995;237:91-105.
4. Evans RT, Wardell J, Rapier C. Laboratory study of the proficiency of cholinesterase phenotyping.
Clin Chem 1983;29:786-788.
5. Evans RT, Walker A. Bowness K.M. Improved Accuracy of Cholinesterase Phenotyping after
Participation in the Proficieny Survey. Clin. Chem. 1987;33:823-825.
6. Kalow W, Lindsay HA. A comparison of optical and manometric methods for the assay of
human serum cholinesterase. Can J Biochem Physiol 1955;33:568-574.
7. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. A new and rapid colorimetric
determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
8. Brock A. Immunoreactive plasma cholinesterase (EC 3.1.1.8) substance concentration,
compared with cholinesterase activity concentration and albumin: Inter- and intra-individual
variations in a healthy population group. J Clin Chem Clin Biochem 1990;28:851-856.
9. Fraser CG. The application of theoretical goals based on biological variation data in proficiency
testing. Arch Pathol Lab Med 1988;112:404-415.
10. Fraser CG, Petersen PH, Ricos C, Haeckel R. Proposed quality specifications for the imprecision
and inaccuracy of analytical systems for clinical chemistry. Eur J Clin Chem Clin Biochem
1992;30:311-317.
Simeon-Rudolf V, Evans RT. INTERLABORATORY STUDY OF CHOLINESTERASE ACTIVITY MEASUREMENT
Arh Hig Rada Toksikol 2001;52:299-305oo
305
11. Flegar-MeπtriÊ Z, ©urina B, ©iftar Z. Biological variations of human serum butyrylcholinesterase
activity in a population from Zagreb, Croatia. Chemico-Biological Interactions 1999;119-120:
193-199.
12. Cooper BE, Statistics for experimentalists, Pergamon Press, Oxford, 1969.
13. Simeon V, BuntiÊ A, ©urina B, Flegar-MestriÊ Z. Cholinesterase phenotyping and distribution of
activity in sera of 346 individuals. Acta Pharm Jugosl 1987;37:107-114.
Saæetak
ME–ULABORATORIJSKA PROVJERA KAKVO∆E MJERENJA AKTIVNOSTI
SERUMSKE KOLINESTERAZE
Mjerenje aktivnosti serumske kolinesteraze vaæna je zadaÊa kliniËkih laboratorija. Smanjena aktivnost kolinesteraze upuÊuje na
smanjenje funkcije jetre ili moæe biti znak i mjera stupnja izloæenosti organskofosfornim spojevima i karbamatima. Serumska
kolinesteraza (butirilkolinesteraza) razgrauje kratkodjelujuÊe miπiÊne relaksanse kao πto je sukcinilkolin, pa je prije njihove
primjene pacijentima potrebno provjeriti aktivnost toga enzima u serumu. Kako bi se osigurao visoki analitiËki standard mjerenja,
poæeljno je da laboratorij sudjeluje u programima kontrole kakvoÊe mjerenja. Tijekom Ëetiri i pol godine proveden je program
provjere osposobljenosti laboratorija za mjerenje aktivnosti kolinesteraze u serumu. U programu je sudjelovalo u prosjeku trideset
pet laboratorija. Svakom laboratoriju poslano je u 18 navrata po 8 uzoraka ljudskog seruma. Laboratoriji su mjerili aktivnost
metodom koja je veÊ bila uvedena u dotiËnom laboratoriju. U prosjeku oko 16 laboratorija rabilo je benzoilkolin kao supstrat za
mjerenje aktivnosti kolinesteraze, a ostali laboratoriji rabili su tiokolinske supstrate. Nepreciznost mjerenja svakog laboratorija
provjeravana je usporedbom uzoraka u duplikatu i analizom rezultata mjerenja 6 uzoraka, koji su bili prireeni mijeπanjem u
odreenom omjeru jednog uzorka velike i jednog uzorka male ili nikakve aktivnosti: omjere mijeπanja znao je samo organizator.
Od 4964 razaslana uzorka, 95% ih je bilo analizirano i laboratoriji su poslali svoje nalaze organizatoru. Prilikom iduÊeg slanja
uzoraka sudionici su dobili rezultate svoje analize, kao i rezultate drugih laboratorija. Organizator je ukupno primio 596 izvjeπtaja s
nalazima mjerenja aktivnosti uzoraka. U oko 34% izvjeπtaja rezultati su dobiveni s nepreciznoπÊu mjerenja manjom od 5%, dok je u
38% izvjeπtaja bilo barem jedno mjerenje odreeno s nepreciznoπÊu veÊom od 10%. Mjerenja obavljena s benzoilkolinom kao
supstratom bila su nepreciznija nego ona s tiokolinskim supstratom, ali razlika u nepreciznosti nije bila dovoljno velika da bi se
laboratorijima savjetovalo da promijene supstrat u svojim mjerenjima.
Na osnovi iscrpne analize rezultata koju su redovito dobivali, sudionici su mogli procijeniti svoju osposobljenost za mjerenje
aktivnosti toga enzima i, ako je bilo potrebno, poboljπati svoja mjerenja. U drugom dijelu programa poveÊao se broj izvjeπtaja s
nalazima veÊe preciznosti.
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benzoilkolin, butirilkolinesteraza, kontrola kakvoÊe mjerenja, ljudska serumska kolinesteraza, nepreciznost mjerenja, priprava
uzoraka za analizu, provjera struËnosti, supstrati, tiokolini
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